Succinic acid salt of biphenyl2-ylcarbamic acid 1-[2-(2-chloro-4-{ [ (R)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) ethylaminoimethyl] } -5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders

Details for Australian Patent Application No. 2007213767 (hide)

Owner Glaxo Group Limited

Inventors Mallet, Franck Patrick; Kindon, Leanda Jane; Chudasama, Reshma; Kennedy, Andrew

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007213767

PCT Pub. Number WO2007/090859

Priority 0602778.3 10.02.06 GB

Filing date 8 February 2007

Wipo publication date 16 August 2007

Acceptance publication date 26 April 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/090859 Priority application(s): WO2007/090859

26 April 2012 Application Accepted

  Published as AU-B-2007213767

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007213778-Low-emission PBT obtained by injection moulding with a degassing device

2007213752-Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation